Dagenais GR, Leong DP, Rangarajan S, Lanas F, Lopez-Jaramillo P, Gupta R, et al. Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study. Lancet Lond Engl. 2020;395:785–94.

Article  Google Scholar 

Jones DS, Podolsky SH, Greene JA. The Burden of Disease and the changing Task of Medicine. N Engl J Med. 2012;366:2333–8.

Article  CAS  PubMed  Google Scholar 

Abramov D, Kobo O, Mamas MA. Association of Cardiovascular Health Metrics and Mortality among individuals with and without Cancer. J Am Heart Assoc. 2024;13:e032683.

Article  PubMed  PubMed Central  Google Scholar 

Leiva O, AbdelHameid D, Connors JM, Cannon CP, Bhatt DL. Common pathophysiology in Cancer, Atrial Fibrillation, atherosclerosis, and thrombosis. JACC CardioOncology. 2021;3:619–34.

Article  PubMed  PubMed Central  Google Scholar 

Carrillo-Estrada M, Bobrowski D, Carrasco R, Nadler MB, Kalra S, Thavendiranathan P, et al. Coronary artery disease in patients with cancer: challenges and opportunities for improvement. Curr Opin Cardiol. 2021;36:597–608.

Article  PubMed  Google Scholar 

Demers M, Krause DS, Schatzberg D, Martinod K, Voorhees JR, Fuchs TA, et al. Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc Natl Acad Sci. 2012;109:13076–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim Y-W, Byzova TV. Oxidative stress in angiogenesis and vascular disease. Blood. 2014;123:625–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Santucci C, Carioli G, Bertuccio P, Malvezzi M, Pastorino U, Boffetta P, et al. Progress in cancer mortality, incidence, and survival: a global overview. Eur J Cancer Prev. 2020;29:367–81.

Article  PubMed  Google Scholar 

Al-Kindi SG, Oliveira GH. Prevalence of Preexisting Cardiovascular Disease in patients with different types of Cancer. Mayo Clin Proc. 2016;91:81–3.

Hassan SA, Palaskas N, Kim P, Iliescu C, Lopez-Mattei J, Mouhayar E, et al. Chemotherapeutic agents and the risk of ischemia and arterial thrombosis. Curr Atheroscler Rep. 2018;20:10.

Article  PubMed  Google Scholar 

Herrmann J, Yang EH, Iliescu CA, Cilingiroglu M, Charitakis K, Hakeem A, et al. Vascular toxicities of Cancer therapies: The Old and the new– an Evolving Avenue. Circulation. 2016;133:1272–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lipshultz SE, Adams MJ, Colan SD, Constine LS, Herman EH, Hsu DT, et al. Long-Term Cardiovascular toxicity in children, adolescents, and young adults who receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and research directions: A Scientific Statement from the American Heart Association. Circulation. 2013;128:1927–95.

Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, et al. Risk of ischemic heart disease in women after Radiotherapy for breast Cancer. N Engl J Med. 2013;368:987–98.

Yakupovich A, Davison MA, Kharouta MZ, Turian J, Seder CW, Batus M, et al. Heart dose and coronary artery calcification in patients receiving thoracic irradiation for lung cancer. J Thorac Dis. 2020;12:223–31.

Article  PubMed  PubMed Central  Google Scholar 

Eriksson F, Gagliardi G, Liedberg A, Lax I, Lee C, Levitt S, et al. Long-term cardiac mortality following radiation therapy for Hodgkin’s disease: analysis with the relative seriality model. Radiother Oncol. 2000;55:153–62.

Article  CAS  PubMed  Google Scholar 

Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the management of patients with chronic coronary disease. J Am Coll Cardiol. 2023;82:833–955.

Article  PubMed  Google Scholar 

Dursun B, He Z, Somerset H, Oh D-J, Faubel S, Edelstein CL. Caspases and calpain are independent mediators of cisplatin-induced endothelial cell necrosis. Am J Physiol-Ren Physiol. 2006;291:F578–87.

Article  CAS  Google Scholar 

Kooijmans EC, Bökenkamp A, Tjahjadi NS, Tettero JM, Van Dulmen-den Broeder E, Van Der Pal HJ et al. Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer. Cochrane Childhood Cancer Group, editor. Cochrane Database Syst Rev [Internet]. 2019 [cited 2024 Nov 24];2019. Available from: https://doi.org/10.1002/14651858.CD008944.pub3

Curigliano G, Lenihan D, Fradley M, Ganatra S, Barac A, Blaes A, et al. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Ann Oncol. 2020;31:171–90.

Article  CAS  PubMed  Google Scholar 

Raebel MA, Zeng C, Cheetham TC, Smith DH, Feigelson HS, Carroll NM, et al. Risk of breast Cancer with Long-Term Use of Calcium Channel blockers or Angiotensin-converting enzyme inhibitors among older women. Am J Epidemiol. 2017;185:264–73.

Article  PubMed  Google Scholar 

Barron TI, Connolly RM, Sharp L, Bennett K, Visvanathan K. Beta blockers and breast Cancer mortality: a Population- based study. J Clin Oncol. 2011;29:2635–44.

Article  CAS  PubMed  Google Scholar 

Zaborowska-Szmit M, Szmit S, Olszyna-Serementa M, Badurak P, Zajda K, Janowicz-Żebrowska A, et al. Beta blockers with statins May decrease all-cause mortality in patients with Cardiovascular diseases and locally Advanced Unresectable Non-small-cell Lung Cancer after Chemoradiotherapy. Cancers. 2023;15:1277.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tornio A, Pasanen MK, Laitila J, Neuvonen PJ, Backman JT. Comparison of 3-Hydroxy‐3‐methylglutaryl Coenzyme A (HMG‐CoA) reductase inhibitors (statins) as inhibitors of cytochrome P450 2C8. Basic Clin Pharmacol Toxicol. 2005;97:104–8.

Article  CAS  PubMed  Google Scholar 

Follet J, Corcos L, Baffet G, Ezan F, Morel F, Simon B, et al. The association of statins and taxanes: an efficient combination trigger of cancer cell apoptosis. Br J Cancer. 2012;106:685–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li L, Wang H, Zhang S, Gao S, Lu X, Pan Y et al. Statins inhibit paclitaxel-induced PD-L1 expression and increase CD8 + T cytotoxicity for better prognosis in breast cancer. Int J Surg [Internet]. 2024 [cited 2024 Nov 24]; Available from: https://journals.lww.com/https://doi.org/10.1097/JS9.0000000000001582

Leong DP, Waliany S, Abdel-Qadir H, Atkins KM, Neilan TG, Lang NN et al. Cardiovasc Considerations Dur Cancer Therapy JACC CardioOncology. 2024;S266608732400348X.

Khan SU, Singh M, Valavoor S, Khan MU, Lone AN, Khan MZ, et al. Dual antiplatelet therapy after percutaneous coronary intervention and drug-eluting stents: a systematic review and network Meta-analysis. Circulation. 2020;142:1425–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tao DL, Tassi Yunga S, Williams CD, McCarty OJT. Aspirin and antiplatelet treatments in cancer. Blood. 2021;137:3201–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, Mehta Z. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet. 2012;379:1591–601.

Article  CAS  PubMed  Google Scholar 

Collet J-P, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42:1289–367.

Article  PubMed  Google Scholar 

Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, et al. Ticagrelor versus Clopidogrel in patients with Acute Coronary syndromes. N Engl J Med. 2009;361:1045–57.

Article  CAS  PubMed  Google Scholar 

Mrotzek SM, Lena A, Hadzibegovic S, Ludwig R, Al-Rashid F, Mahabadi AA, et al. Assessment of coronary artery disease during hospitalization for cancer treatment. Clin Res Cardiol. 2021;110:200–10.

Article  PubMed  Google Scholar 

Van Werkum JW, Heestermans AA, Zomer AC, Kelder JC, Suttorp M-J, Rensing BJ, et al. Predictors of coronary stent thrombosis. J Am Coll Cardiol. 2009;53:1399–409.

Article  PubMed  Google Scholar 

Han X, Li J, Khannanova Z, Li Y. Optimal management of coronary artery disease in cancer patients. Chronic Dis Transl Med. 2019;5:221–33.

PubMed  Google Scholar 

Li Z, Liu B, Ge W, Zhang W, Gu C, Liu J, et al. Effect of simultaneous surgical treatment of severe coronary artery disease and lung cancer. J Int Med Res. 2019;47:591–9.

Article  PubMed  Google Scholar 

Iliescu C, Tsitlakidou D, Giza D, Marmagkiolis K. Wayne State University, Detroit, MI, USA, Florida Hospital, Pepin Heart Institute, Tampa, FL, USA. Primary percutaneous coronary interventions in Cancer patients. Cancer Res Front. 2017;3:64–71.

Article